Prediction Markets Criticized for Clinical Trial Bets
#ClinicalTrials #PredictionMarketsKalshi and Polymarket now allow betting on clinical trial outcomes, drawing criticism from researchers and patients' families who warn of insider trading, tampering risks, and ethical harm. Critics call profiting from trial failures "ghastly," while platforms defend the practice as informative. read more
#MaleBirthControl #ClinicalTrials
A hormonal gel in clinical trials for male birth control is showing promise with participants experiencing decreased sperm counts, potentially providing a safer, reversible alternative. Challenges in developing male contraception have historically existed due to biological differences. read more